Citation Impact
Citing Papers
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Verapamil
1989
DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION
1989
Cellular Events in the Bronchi in Mild Asthma and after Bronchial Provocation
1989
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study)
1995
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Eosinophilic Inflammation in Asthma
1990 Standout
Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
1990
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy
1990
A simulation study of the number of events per variable in logistic regression analysis
1996 Standout
Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis
1995
Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study)
1989
From myocardial salvage to patient salvage in acute myocardial infarction: The role of reperfusion therapy
1989
Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
1990
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Development of a rational scale to assess the harm of drugs of potential misuse
2007 Standout
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
2009 StandoutNobel
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis
1990
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis
1993
Fish Intake, Contaminants, and Human Health
2006 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Which thrombolytic agent should one choose?
1991
A Sensitive Thyroid Stimulating Hormone Assay for Screening of Thyroid Functional Disorder in Elderly Japanese
1989
Subclinical Thyroid Disease
2004 Standout
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Drug Policy: Striking the Right Balance
1990 Science
Revisiting Reperfusion Therapy in Inferior Myocardial Infarction
1997
Cardiac Myxomas
1995 Standout
Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
1989
Complications of Endoscopic Biliary Sphincterotomy
1996 Standout
Reperfusion therapy in inferior myocardial infarction
1988
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversies
1990
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock
1991
Protein therapeutics: a summary and pharmacological classification
2007 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Biomarkers in Heart Failure
2008 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Identification of meta-analyses
1990
Asthma
2000 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study
2002
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
2008
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.
1989
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Guidelines for the early management of patients with acute myocardial infarction
1990
A Double-Blind Trial of Metoprolol in Acute Myocardial Infarction
1983
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
2002 Standout
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
1995
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence
1995
Guidelines for the Primary Prevention of Stroke
2014 Standout
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
Clinical and echocardiographic features of right atrial masses
1984
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
The Risk of Determining Risk with Multivariable Models
1993 Standout
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.
1996 Standout
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
1992
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
TIMI Frame Count
1996 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
1988 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Works of J. Federman being referenced
Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction
1988
Right Atrial Thrombus Simulating Myxoma on M-Mode Echocardiography in a Patient with Pulmonary Emboli
1982
A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.
1991
Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome
1982
The Effect of a Selective Beta Adrenergic Blocking Agent on Ventricular Arrhythmias in the First Year Following Myocardial Infarction*
1980